Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
about
Trends in the prevalence and management of diagnosed type 2 diabetes 1994-2001 in England and WalesImplications of the problem orientated medical record (POMR) for research using electronic GP databases: a comparison of the Doctors Independent Network Database (DIN) and the General Practice Research Database (GPRD)Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001Secondary prevention of coronary heart disease in older British men: extent of inequalities before and after implementation of the National Service FrameworkPrevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities: a population-based studyGender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary careExtracting Electronic Health Record Data in a Practice-Based Research Network: Processes to Support Translational Research across Diverse Practice OrganizationsTime trends in the prescription of statins for the primary prevention of cardiovascular disease in the United Kingdom: a cohort study using The Health Improvement Network primary care dataWhat impact did the creation of Local Health Care Co-operatives have on indicators of practice resources and activity?The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study.Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance.Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.Statins and their interactions with other lipid-modifying medications: safety issues in the elderlyRosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.Statin utilization in nursing home patients after cardiac hospitalizationFactors associated with statin treatment for the primary prevention of cardiovascular disease in people within 2 years following diagnosis of diabetes in Scotland, 2006-2008.Optimizing secondary prevention: Statin prescribing across East and West London in accordance with NICE guidelines.Initiation rates of statin therapy for the primary prevention of cardiovascular disease: an assessment of differences between countries of the UK and between regions within England.Timing of routine immunisations and subsequent hay fever riskCan analyses of electronic patient records be independently and externally validated? Study 2--the effect of β-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study.Evidence for inequalities in the management of coronary heart disease in Scotland.The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003.Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care.Recent trends in (under)treatment of hypercholesterolaemia in the NetherlandsDrug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002.Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.A mobile screening programme for the cardiovascular and microvascular complications of Type 2 diabetes in primary care.Management of type 2 diabetes with multiple oral hypoglycaemic agents or insulin in primary care: retrospective cohort studySpurious trends in coronary heart disease incidence: unintended consequences of the new GP contract?Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.Evaluating quality and its determinants in lipid control for secondary prevention of heart disease and stroke in primary care: a study in an inner London Borough.Age and sex interaction in reported help seeking in response to chest pain.Trends and inequities in beta-blocker prescribing for heart failure.Influence of patients' coronary artery calcium on subsequent medication use patternsSociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort studyManagement of hyperlipidemia in older adults.10-year trends in statin utilization in Taiwan: a retrospective study using Taiwan's National Health Insurance Research Database.Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?
P2860
Q24792900-097CE445-916A-4EE6-9545-EFFCC996593EQ24806013-A8D74E91-946E-498A-9145-B6F24C0674F8Q28168028-C9F86C5F-476A-4D01-91DC-91CCDDC439DCQ28191878-AB993E90-BAAC-4FA8-9B08-3DBE8F4E9F76Q28194404-3C883463-6F01-4F32-A6BA-788E2600E0F2Q28220836-BF05C087-6158-47FB-B4DC-5435687195ECQ31089851-A10FA904-D57E-4143-80D6-1B946483F332Q31108693-9E929B82-97CA-4DDA-BA0A-107578E7C6D6Q33335365-9D188CFD-E1FE-4FB7-B4A4-92B83F6B10D2Q33514949-EAF2A570-929B-4697-8F2A-7D618763810CQ33724790-DBEE5264-DD6A-41B0-AC7A-8F434C113E22Q33783232-F1A8846B-D854-4B59-B89F-1CA3E9423DF8Q33949348-51608010-912F-4B94-A69E-6FD7FB99B597Q34158442-1288779F-8A05-4410-AD4F-94408C18E579Q34332714-1CACF547-F995-49E1-AC17-FF1E66EDBEB5Q34516311-F89AF7D4-3DF1-4C79-B344-42E0D920BCB4Q35138373-B617224B-7218-4B97-8850-3D7C54894425Q35179448-D1EB3227-5692-465B-B2CF-D0A932E2F8BAQ35283651-B16D2FE5-FFEF-4532-A119-F606FEF8DB69Q35466477-40B70DF8-6BB5-4430-8AAF-08DBBE81CA50Q35584106-1BB982D8-ED2E-4656-B421-F144987ADFC2Q35761955-DAC5184B-7098-417B-A30C-6AC7AFAEE373Q35772239-6C0803A2-9EBA-450C-B169-786BFDA98917Q35826287-E4E709D8-33D2-4F70-98A8-EBEE33E27EDBQ35826495-81B1E381-B294-4092-A945-48039CDB79FBQ35826739-8A759307-3569-4DA8-B805-AB5C1594C0EFQ35827218-C9DFE93F-94C8-4FC2-8C5B-A5E68795113FQ36045916-AECEFEC8-FA12-43BE-A012-B06F206B3DC1Q36144497-CB93010A-8206-4799-B02A-959031BAA81AQ36144574-73835F16-F37D-44D6-BDA3-F2C172ACA6E9Q36360311-1BD73C98-B2D0-4EE8-85A5-B60D52D04DD4Q36374194-526BC2E3-39C3-4E73-81E4-075FA2E124C6Q36732751-8CB55D34-0BC7-4509-A743-E250D6FF6E24Q36995236-93DAE180-DEDD-4557-A656-34D0B4990517Q37121310-EDA60CD8-20F3-4C62-9520-CD15CC7983E5Q37160346-93973A40-AC2B-452E-987B-1DE9F69029B3Q37362818-068A71FD-B478-4521-8088-CA8BC53645C9Q38780165-BF83CFFB-F7AE-4502-98AA-93517415FE16Q39958104-C81F1C67-ED45-494D-8A71-7C0F6EC70200Q40455288-7A5341C9-7196-44FD-AFE0-4E2E8AF90000
P2860
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@ast
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@en
type
label
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@ast
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@en
prefLabel
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@ast
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@en
P2093
P2860
P356
P1433
P1476
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism?
@en
P2093
P2860
P304
P356
10.1136/HEART.89.4.417
P407
P577
2003-04-01T00:00:00Z